Andrei Aziz
YOU?
Author Swipe
View article: FABP5 Inhibition against PTEN-Mutant Therapy Resistant Prostate Cancer
FABP5 Inhibition against PTEN-Mutant Therapy Resistant Prostate Cancer Open
Resistance to standard of care taxane and androgen deprivation therapy (ADT) causes the vast majority of prostate cancer (PC) deaths worldwide. We have developed RapidCaP, an autochthonous genetically engineered mouse model of PC. It is dr…